Johnson & Johnson Ordered to Pay Woman With Ovarian Cancer $110M | NBC4 Washington
National & International News
The day’s top national and international news

Johnson & Johnson Ordered to Pay Woman With Ovarian Cancer $110M

A Virginia woman who was diagnosed with ovarian cancer blames the company's talcum-containing products for her illness

    processing...

    NEWSLETTERS

    A woman's death has been linked to Johnson & Johnson's talcum powder. Full statement from Johnson & Johnson: “The talc used in all our global products is carefully selected and meets the highest quality, purity and compliance standards. The recent U.S. verdict goes against decades of sound science proving the safety of talc as a cosmetic ingredient in multiple products, and while we sympathize with the family of the plaintiff, we strongly disagree with the outcome.” (Published Wednesday, Feb. 24, 2016)

    A St. Louis jury has awarded a Virginia woman a record-setting $110.5 million in the latest lawsuit alleging that using Johnson & Johnson's baby powder caused cancer.

    The jury ruling Thursday night for 62-year-old Lois Slemp, of Wise, Virginia, comes after three previous St. Louis juries awarded a total of $197 million to plaintiffs who made similar claims. Those cases, including the previous highest award of $72 million, are all under appeal.

    Slemp, who was diagnosed with ovarian cancer in 2012, blames her illness on her use of the company's talcum-containing products for more than 40 years. Her cancer has spread to her liver, and she was too ill to attend the trial. About 2,000 state and federal lawsuits are in courts across the country over concerns about health problems caused by prolonged talcum powder use.

    Johnson & Johnson, based in Brunswick, New Jersey, said in a statement that it would appeal and disputed the scientific evidence behind the plaintiffs' allegations. The company also noted that a St. Louis jury found in its favor in March and that two cases in New Jersey were thrown out by a judge who said there wasn't reliable evidence that talc leads to ovarian cancer.

    Johnson & Johnson to Pay $55M in Talc Cancer Case

    [NATL-PHI] Johnson & Johnson to Pay $55M in Talc Cancer Case

    A woman blames Johnson & Johnson's talcum powder for her ovarian cancer.

    (Published Friday, May 5, 2017)

    "We are preparing for additional trials this year and we will continue to defend the safety of Johnson's Baby Powder," the statement said.

    Talc is a mineral that is mined from deposits around the world, including the U.S. The softest of minerals, it's crushed into a white powder. It's been widely used in cosmetics and other personal care products to absorb moisture since at least 1894, when Johnson & Johnson's baby powder was launched. But it's mainly used in a variety of other products, including paint and plastics.

    Much research has found no link or a weak one between ovarian cancer and using baby powder for feminine hygiene, and most major health groups have declared talc harmless. Still, the International Agency for Research on Cancer classifies genital use of talc as "possibly carcinogenic."

    Attorneys with Onder, Shelton, O'Leary & Peterson, the firm that handled the St. Louis cases, cited other research that began connecting talcum powder to ovarian cancer in the 1970s. They cite case studies showing that women who regularly use talc on their genital area face up to a 40 percent higher risk of developing ovarian cancer.